Advertisements

Адолен

Quick links to important sections

Адолен

Advertisements
Advertisements

Treatment option: Zits, Blackheads, Acne Vulgaris

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Адолен

Quick Facts

Property Description
Active ingredient Adapalene
Form Cream, Gel, Lotion, Solution
Pharmacological class Dermatologic drug, Keratolytic agent, Retinoid-like compound
General Use Anti-acne preparation
Origin Synthetic (Naphthoic acid derivative)

What Type of Medicine is Адолен (Adapalene)?

Адолен is a medicinal preparation whose active substance is Adapalene, a synthetic retinoid used exclusively for topical administration to the skin. This compound is chemically defined as a naphthoic acid derivative and functions as a highly targeted keratolytic agent, placing it within the broader dermatologic drug class. Adapalene is distinguished as a third-generation retinoid, possessing high structural stability and selective action. This synthetic origin is key, as it affords the molecule greater photochemical stability compared to older retinoid generations.

Composition, Origin, and Topical Forms

The active substance Adapalene is a synthetic molecule, intentionally designed to improve stability and receptor targeting. The medication is delivered via the topical route and is available in various dosage forms, most commonly as a non-greasy gel, a moisturizing cream, or a light lotion. The specific presentation is often tailored to the target patient group and their skin type. The composition of Адолен involves the active ingredient combined with a pharmaceutical base/vehicle—such as an aqueous cream emulsion or a glycol-based formulation—which is essential for controlled delivery into the skin.

General Purpose and Core Action

The general purpose of this retinoid-like compound is to serve as an anti-acne preparation by correcting fundamental cellular processes. The mechanism involves modulating the growth and differentiation of follicular epithelial cells, thereby preventing the abnormal cellular cohesion and buildup that leads to follicular blockage. Adapalene demonstrates the ability to normalize skin cell growth and reduce inflammation at the site of application. This normalization of follicular epithelial cell differentiation provides the general therapeutic benefit: assisting the skin in maintaining a clearer, properly functioning structure.

Advertisements

What side effects are possible with Адолен?

Possible side effects and safety information

The safety profile for Adapalene, the active ingredient in Адолен, is officially structured around expected local skin reactions, with specific attention given to time-related patterns and rare systemic events documented in regulatory sources.

Frequency-Classified Adverse Reactions

The majority of documented adverse reactions involve the application site, classified according to official frequency standards:

Classification Examples of Adverse Reactions (Skin and Subcutaneous Tissue Disorders)
Very Common (10–40%) Erythema (redness), Scaling, Dryness, Pruritus (itching), Burning sensation
Common (≥1%) Skin discomfort/pain, Desquamation (peeling), Sunburn, Application site pain
Uncommon (<1%) Acne flare, Contact dermatitis, Eyelid edema, Conjunctivitis, Skin discoloration

Serious Adverse Reactions and Safety Constraints

Adverse reactions affecting the Immune System are noted in postmarketing reports, including rare occurrences of serious systemic hypersensitivity reactions such as Angioedema and Anaphylaxis. These events are classified as having a Not Known frequency due to the nature of postmarketing data collection.

Official labeling defines key time-related patterns: The most frequent local reactions are most likely to occur during the first two to four weeks of treatment and generally lessen with continued use. Furthermore, regulatory constraints require patients to minimize exposure to sunlight or sunlamps because the medication can cause photosensitivity, increasing the risk of sunburn.

Population and Contextual Safety

Regulatory documents include specific safety language regarding use in certain populations. For pregnancy, use is contingent upon a benefit/risk assessment, noting that high oral doses in animal studies showed teratogenic effects. It is unknown whether the active substance is excreted in human milk during lactation. The medication is officially approved for use in the pediatric population from 12 years of age.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help: Official Regulatory Information

The official regulatory profile for Адолен overdose is defined by the exposure route, as the medicine is intended for cutaneous use only.

Documented Overdose Presentations

Excessive topical application is documented to cause signs of localized skin toxicity, specifically marked redness, peeling, and discomfort. Regulatory labeling explicitly notes that applying amounts larger than instructed will not produce more rapid or better therapeutic results. Systemic toxicity is a distinct concern associated with accidental oral ingestion. Chronic oral ingestion may lead to physiological effects similar to those associated with excessive oral intake of Vitamin A (Hypervitaminosis A syndrome).

Required Emergency Actions

Immediate medical attention must be sought for all suspected overdose scenarios. Official guidance mandates contacting a Poison Control Center. Furthermore, local emergency services must be contacted if the affected individual is collapsed or not breathing. The documented management strategy is strictly symptomatic and supportive, and consideration of procedures such as gastric emptying for non-small quantities is advised, as no specific antidote is known for this compound.

Advertisements

Therapeutic Uses of Адолен

What Адолен treats: Main Uses and Benefits

The medication is commonly used to address the chronic skin condition Acne Vulgaris in adolescents and adults, supporting the management of symptoms that interfere with daily functioning. Adapalene is primarily relevant for easing the symptom burden in conditions characterized by periods of heightened physiological activity and localized discomfort.

This medication may be part of symptomatic management for conditions presenting with systemic or localized discomfort, specifically addressing non-inflammatory comedones (blackheads and whiteheads) and mild to moderate inflammatory lesions (papules and pustules). It is typically applied across domains where additional symptomatic support is needed, primarily serving as a long-term maintenance therapy for acne-prone skin.

“This application supports the patient during difficult episodes by easing distress and contributes to improved comfort during symptomatic periods.”

Quick Fact: Relief for Acne Symptoms

Symptomatic Domain Core Therapeutic Benefit
Pore Blockages (Comedones) Is used for managing existing clogs and assists with preventing new lesions from forming.
Inflammatory Manifestations (Papules/Pustules) Supports the easing of visible redness and swelling associated with active spots.
Recurrence Prevention Contributes to maintaining functional stability and easing the overall symptom load.

Regulatory References

  1. NIH MedlinePlus overview
Advertisements

Eligibility and Restrictions for Use

Eligibility for Адолен (Adapalene): Official Regulatory Status

Population eligibility for Adapalene topical formulations is strictly defined by regulatory documents based on age, physiological status, and the integrity of the application site.

Eligibility Classification Population / Condition
Absolute Contraindication Individuals with known hypersensitivity to Adapalene or any components.
Absolute Contraindication Pregnant women or women planning a pregnancy (as stated by EMA and other international bodies).
Established Use Patients 12 years of age and older for the topical treatment of acne vulgaris.
Use Not Established Pediatric patients below 12 years and geriatric patients 65 years and older (due to insufficient clinical data).
Conditional Use/Avoidance Nursing mothers (use must be restricted to the smallest area of skin for the shortest duration; avoid application to areas where the infant may ingest the product).
Conditional Use/Avoidance Damaged skin, including cuts, abrasions, severe sunburn, or eczema. The product must not be applied to these areas.

These official statements establish that while the medication is cleared for use in adolescents and adults over 12, its use is strictly prohibited in cases of allergy or pregnancy, and it requires careful limitation when applied by nursing mothers or to compromised skin.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Due to the minimal systemic absorption of the active ingredient Adapalene through the skin, the regulatory labeling indicates that interaction with systemic medicinal products taken orally is unlikely. Formal drug-drug interaction studies with systemic medicines were not conducted, and the official assessment confirms no evidence that the topical application influences the effectiveness of commonly co-administered oral drugs, such as oral contraceptives or antibiotics.

Interactions with Topical Products

The fundamental constraint documented in the official profile is a pharmacodynamic risk resulting in a cumulative irritancy effect at the application site.

  • Restricted Combinations: The co-administration of Adapalene with other topical retinoids or drugs with a similar mode of action is officially restricted and should not be used concurrently.
  • Irritating Substances: Caution must be exercised with topical products that possess abrasive or strong drying properties. This includes medicated soaps, abrasive cleansers, and cosmetics. This caution extends to products with high concentrations of alcohol, astringents, spices, or lime due to the potential for additive irritation.
  • Administration Timing: If preparations containing keratolytic agents such as Sulfur, Resorcinol, or Salicylic acid have been used, the official guidance advises against starting Adapalene therapy until the effects of those prior preparations on the skin have fully subsided.

Food and Other Substances

Regulatory documents affirm that there are no known interactions between Adapalene and food or drinks.

Advertisements

Mechanism of Action

Molecular Control of Gene Expression

This mechanism is initiated by the drug acting as a selective agonist for Retinoic Acid Receptors (RARs), primarily the RAR-gamma subtype, within the cell nucleus. By binding to these receptors and modulating gene transcription, the drug engages regulatory mechanisms that modulate the gene expression profile of the skin's epithelial cells.


️ Normalizing Follicular Cell Architecture

The resulting genomic signaling modulates the irregular maturation and excessive cohesion of the cells lining the hair follicle, a process known as hyperkeratinization. This modulation of cellular architecture modifies the early molecular steps that lead to blockage, leading to comedolytic and anti-comedogenic activity that contributes to the normalization of the pilosebaceous unit's structure.


️ Functional Suppression of Inflammation

The drug also exerts a direct inhibitory effect on key signaling elements, such as Toll-like Receptor 2 (TLR-2) and the AP-1 pathway, which are responsible for activating the skin's innate immune response. This suppression of inflammatory transcription factors results in the suppression of the inflammatory response and reducing the activity of excessive mediators at the site of action.

Advertisements

Dosage and Administration Information

The use of Adapalene (Адолен) involves specific administration routes and standard dosing schedules. It is exclusively an externally applied medication, available in various formulations—including gel, cream, lotion, and solution—typically at concentrations of 0.1% or 0.3%. The standard pattern for administration involves applying a thin film of the product to the affected skin area once per day, generally scheduled for the evening or at bedtime. The skin must be gently cleansed and dried prior to application.

Administration Domain Usage Principle
Route Topical (External cutaneous use only)
Dosing Frequency Once daily (QD), typically in the evening
Application Area The entire affected area, not only individual lesions
Pediatric Use Approved for individuals aged 12 years and older

The established protocol for this medication emphasizes applying the product to the entire affected area rather than only spot treating. This approach facilitates long-term maintenance, with therapeutic effects often becoming noticeable after a sustained period of 8 to 12 weeks. Procedurally, it is important to avoid all contact with sensitive zones, including the eyes, lips, and other mucous membranes. This administration protocol ensures the consistent, targeted delivery of the drug.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Адолен

Overview of Research for Acne Vulgaris (The Primary Indication)

The clinical evidence for Adapalene is primarily derived from randomized controlled trials (RCTs). These trials are a principal type of study in which subjects are randomly assigned to receive either the active medicine or an inactive product (a vehicle or placebo). This research explored the compound's use in the management of mild to moderate Acne Vulgaris in adolescents and adults.

In these trials, researchers primarily monitored two key outcomes: changes in lesion counts and an overall clinical grading by the study physician. They differentiated between non-inflammatory spots (blackheads and whiteheads) and inflammatory spots (papules and pustules). The studies were used in research exploring how symptoms change over time, and findings describe patterns observed in the studies, particularly concerning the change in both inflammatory and non-inflammatory symptoms over the study duration.

Types of Clinical Trials and Research Evidence

The evidence base for Adapalene includes a substantial number of multicenter, vehicle-controlled trials. This kind of study helps describe patterns observed in large populations under controlled conditions. Adapalene was also evaluated in comparative studies against some older acne treatments. The consolidation of these individual RCT findings through systematic reviews and meta-analyses contributes to the broader evidence landscape by helping to contextualize how patients reported their experience and how symptoms evolved in the observed populations across different studies.

Evidence also includes data from large-scale, post-marketing surveillance studies. These non-comparative studies were conducted after the medicine was already available and aimed to gather additional information when the compound was used in daily-life functioning by a wider population of patients over extended time intervals. This research primarily describes the patterns of use rather than comparative findings.

What the Scientific Literature Notes as Research Gaps

Scientists and regulatory bodies recognize that limitations exist within the current research landscape. One key area of uncertainty is the relatively limited follow-up durations for comparative efficacy—the highest-quality comparisons are mostly restricted to 12 weeks. This means that long-term outcomes are not fully established using comparative trial methodology. The research largely excluded subjects with the most severe forms of acne (e.g., nodulocystic lesions), and comparative evidence is limited for groups such as children under 12 years of age.

Key Studies & References Adapalene Drug Information Overview (Used for General Use and Patient Context)

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Адолен (FAQ)

Q: Are there any foods or drinks that should be avoided while using Адолен?

Official guidance indicates there are no known interactions between the active ingredient and food or drinks. Because this medicine is applied directly to the skin and has minimal absorption into the bloodstream, no specific foods or beverages are generally recommended for avoidance.

Q: Can Адолен cause problems with sleep or insomnia?

Adverse events reported in clinical trials and official labeling focus mainly on local skin reactions like dryness and scaling. Insomnia or other sleep disturbances are not listed among the very common, common, or uncommon side effects in the official product information.

Q: Is it true that Адолен can interact with blood pressure medications?

Regulatory documents state that interaction with systemic medicinal products, which includes oral blood pressure medications, is unlikely. This is due to the drug’s minimal systemic absorption when applied to the skin, meaning very little of the active ingredient enters the bloodstream.

Q: How often do serious side effects happen with Адолен use?

Rare, serious systemic reactions like anaphylaxis have been noted in postmarketing reports (reports collected after the drug is on the market). However, the frequency of these serious events is classified in official documents as 'Not Known' because this type of data collection does not allow for a reliable estimate of how often they occur.

Q: Can using Адолен make me more sensitive to the sun?

Yes, official warnings confirm that the medication can cause photosensitivity, which increases the risk of sunburn. Because of this, regulatory constraints require minimizing exposure to sunlight or sunlamps, and using protective measures like sunscreen when exposure cannot be avoided.

Q: Is it possible for a side effect not listed in the pamphlet to occur with Адолен?

The official safety profile includes rare adverse events reported during postmarketing surveillance, which means these events were observed after the initial clinical trials. These reactions are listed with a 'Not Known' frequency, confirming that new and rare reactions can be reported even after the medicine is approved.

Q: What if I forget when I last took Адолен?

General guidance for a missed application is to skip the missed dose entirely. Official guidance advises against applying extra medicine to compensate. Instead, simply apply the next dose at its regularly scheduled time (which is typically the following evening).

Q: Why is it important to tell my doctor about all vitamins I take while using Адолен?

Official warnings caution against using the medicine alongside supplements containing high amounts of Vitamin A, which is a related compound. This is to avoid the potential for additive toxicity or increased skin irritation due to the combined effect of the active ingredients.

Q: Does Адолен contain any common allergens like gluten or lactose?

Official labeling for the topical formulation provides a list of inactive ingredients, such as propylene glycol and parabens. However, these regulatory documents do not always explicitly state if the final product is explicitly free of common allergens like gluten or lactose.

Q: What if I've been taking Адолен for a while and feel like it isn't working as well?

Clinical studies indicate that the full therapeutic effect, or the clearest improvement, is generally observed after a sustained period of up to 12 weeks of once-daily use. The clinical trial framework defines this as the expected response period.

Q: Do older adults typically need a different approach when using Адолен?

Official labeling notes that there is currently insufficient clinical data available to compare the use of this medicine in the elderly population (65 years and older) with the use in younger age groups. Therefore, official guidelines do not establish specific dosage or administration protocols for this group.

Q: Is there a risk of becoming dependent on Адолен?

The active ingredient, Adapalene, is classified as not scheduled under the Drug Enforcement Administration (DEA) guidelines. This classification means the medicine is not scheduled under official regulatory guidelines.

Q: Is Адолен considered a narcotic or opioid?

No, this medicine is classified as a topical retinoid, which is a dermatologic drug applied to the skin. It is not listed as a narcotic or opioid under official regulatory classifications.

Q: How long does Адолен stay in your system after stopping its use?

Pharmacokinetic data confirms that the drug has minimal systemic absorption through the skin; only trace amounts enter the bloodstream. These trace amounts are primarily eliminated from the body via the biliary route, which means they are processed and excreted via the liver and bile.

Q: Are there different strengths of Адолен available?

Yes, the active ingredient is generally available in various topical formulations, such as gels, creams, and lotions, at concentrations of 0.1% or 0.3%.

Q: Is Адолен appropriate for teenagers or children?

The medication is officially approved for use in patients who are 12 years of age and older. Official guidance states that use in children younger than 12 years of age is generally not established due to insufficient clinical data.

Q: Are there warnings about using Адолен with herbal supplements?

Official warnings specifically caution against the concurrent use of the drug with supplements containing Vitamin A (a related compound) due to the potential for additive irritation. General warnings about other herbal supplements are not explicitly addressed in the regulatory labeling.

Q: Does Адолен affect birth control pills?

The official assessment indicates that interaction with systemic medicinal products, including oral contraceptives (birth control pills), is unlikely. This is based on the drug's minimal systemic absorption into the bloodstream after topical application.

Q: Is there a generic version of Адолен?

Yes, regulatory information and product labels confirm that a generic version of the active ingredient, Adapalene, is available in various strengths and topical formulations.

Q: Can Адолен affect my mood or cause mood swings?

The adverse reaction profile for the medicine does not list mood swings or other psychiatric side effects among the very common, common, or uncommon reported events in official labeling.

Q: Does Адолен cause drowsiness, even if it's not listed as a common side effect?

Drowsiness or other central nervous system effects are not listed among the adverse reactions in official documents. This is consistent with the drug's minimal systemic absorption, which is why it is used as a topical application.

Q: Does Адолен have any known effects on liver function tests?

The trace amount of the drug that is absorbed systemically is primarily eliminated by the biliary route, which involves the liver. However, official labeling does not include specific warnings or monitoring requirements for liver function tests.

Q: What are the long-term safety considerations for Адолен?

Clinical studies have evaluated the active ingredient for continuous use for up to 52 weeks (one year). Findings generally describe the expected local skin reactions (like dryness, scaling, and redness) as mild to moderate, and these symptoms typically lessen with continued use beyond the first month.

Q: How does the time of day influence when Адолен should be taken?

The official protocol states that the product is typically applied once daily in the evening or at bedtime. This recommendation is made to minimize potential sun exposure while the product is on the skin, as the medication can cause photosensitivity.

Advertisements

How should Адолен be stored and disposed of?

Storage and Disposal Requirements

Official regulatory documents define the storage and disposal of all medicines according to mandatory principles of product stability and public safety.

Domain Regulatory Requirement
Temperature & Protection Storage must meet the specific temperature (e.g., below 25°C) and environmental needs (e.g., protection from light/moisture) defined by stability studies.
Child Safety The medicine must be kept in a secure location, out of the sight and reach of children and pets.
Container Integrity The product must be stored in its original container to preserve its quality and stability until the labeled expiration date.
Disposal Disposal of unused or expired medicine must follow authorized pathways, such as government-sponsored drug Take-Back Programs or pre-paid mail-back envelopes.

If a take-back program is unavailable, non-flushable medicines must be mixed with an unpalatable substance (like dirt or coffee grounds) and sealed in a bag before being placed in household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Адолен found in:

A-Z Index: